Patients with paroxysmal nocturnal hemoglobinuria demonstrate a prothrombotic clotting phenotype which is improved by complement inhibition with eculizumab-Reference-Cited by-同舟云学术

Patients with paroxysmal nocturnal hemoglobinuria demonstrate a prothrombotic clotting phenotype which is improved by complement inhibition with eculizumab

Published:2020-05-11 Issue:8 Volume:95 Page:944-952
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Macrae Fraser L.¹^ORCID,Peacock‐Young Barnaby¹,Bowman Polly¹,Baker Stephen R.¹²^ORCID,Quested Sam¹,Linton Emma¹,Hillmen Peter³,Griffin Morag³,Munir Talha³^ORCID,Payne Daniel³,McKinley Claire⁴,Clarke Deborah⁴,Newton Darren J⁴,Hill Anita³,Ariëns Robert A. S.¹^ORCID

Affiliation:

1. Discovery and Translational Science DepartmentLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds Leeds UK

2. Department of PhysicsWake Forest University Winston Salem North Carolina USA

3. Department of HaematologyLeeds Teaching Hospitals NHS Trust Leeds UK

4. Division of Haematology and ImmunologyLeeds Institute of Medical Research at St James's, University of Leeds Leeds UK

Funder

British Heart Foundation

Wellcome Trust

Publisher

Wiley

Subject

Hematology